Consolidated Planning Corp’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
20,469
+156
+0.8% +$28.3K 0.4% 43
2026
Q1
$2.99M Buy
20,313
+14,238
+234% +$2.31M 0.48% 37
2025
Q4
$1.18M Sell
6,075
-12,494
-67% -$2.97M 0.12% 121
2025
Q3
$5.22M Buy
18,569
+8,436
+83% +$2.15M 0.55% 58
2025
Q2
$2.22M Sell
10,133
-991
-9% -$160K 0.28% 84
2025
Q1
$1.56M Buy
11,124
+7,962
+252% +$1.3M 0.21% 88
2024
Q4
$527K Sell
3,162
-116
-4% -$20.6K 0.07% 125
2024
Q3
$559K Sell
3,278
-4,715
-59% -$683K 0.08% 126
2024
Q2
$1.13M Buy
7,993
+1,050
+15% +$130K 0.19% 86
2024
Q1
$872K Buy
6,943
+400
+6% +$45.8K 0.15% 94
2023
Q4
$690K Buy
6,543
+221
+3% +$24.1K 0.13% 99
2023
Q3
$670K Buy
6,322
+1,605
+34% +$186K 0.15% 98
2023
Q2
$562K Buy
+4,717
New +$488K 0.12% 111
2021
Q4
Sell
-958
Closed -$83K 335
2021
Q3
$83K Buy
+958
New +$84.6K 0.05% 118

Other funds holding ORCL

Consolidated Planning Corp's ORCL Position: Q2 2026 in Review

Consolidated Planning Corp increased its Oracle (ORCL) stake by 0.77% in Q2 2026, buying an estimated $28.3K and bringing the position to 20,469 shares worth $3M. The position accounts for 0.4% of the portfolio, ranked #43.

Consolidated Planning Corp first reported a position in ORCL in Q3 2021 and has held it in 14 quarters since. The position peaked at $5.22M in Q3 2025. 3,529 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Consolidated Planning Corp held 20,469 shares of Oracle worth $3M as of Q2 2026.
  • Consolidated Planning Corp bought 156 Oracle shares in Q2 2026, an estimated $28.3K.
  • Oracle made up 0.4% of Consolidated Planning Corp's portfolio in Q2 2026, its #43 holding.
  • Consolidated Planning Corp first reported a position in Oracle in Q3 2021 and has held it in 14 quarters since.
  • Consolidated Planning Corp's Oracle position peaked at $5.22M in Q3 2025.
  • 3,529 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Consolidated Planning Corp's 13F filing for Q2 2026, filed 24 Jul 2026.